Page 2 - Enabling Services News Today

Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 public companies in the “Medical laboratories” industry, but how does it contrast to its competitors? We will compare Fortrea to similar companies based on the strength of its valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. Valuation and Earnings This table compares Fortrea […]

DURHAM, N.C., May 06, 2024 -- Fortrea , a leading global contract research organization , today announced an updated issuance date for the company’s first quarter 2024 financial results. The...

Vyant Bio (OTCMKTS:VYNT – Get Free Report) and Fortrea (NASDAQ:FTRE – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends. Profitability This table compares Vyant Bio and Fortrea’s net […]

Fortrea (FTRE) posted a fourth quarter GAAP net loss of $36.0 million and loss per share of $0.41 compared to net income of $33.4 million and earnings per share of $0.

For the three months and full year ended December 31, 2023: Revenues of $775.4 million for the fourth quarter, $3,109.0 million for the full yearGAAP net loss of $ million for the fourth quarter, $...

Fortrea (NASDAQ:FTRE – Get Free Report) and Biodesix (NASDAQ:BDSX – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Profitability This table compares Fortrea and Biodesix’s net margins, return […]

Fortrea (NASDAQ:FTRE – Get Free Report) and Biodesix (NASDAQ:BDSX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and […]

HBSE Date Sheet 2024: The Board of School Education, BSEH Haryana has published the date sheet for the class 10, and 12 exams. Get HBSE 10th, 12th Datesheet PDF here.

Fortrea (NASDAQ:FTRE – Get Free Report) and Invitae (NYSE:NVTA – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends. Analyst Ratings This is a summary of current ratings for […]

Haryana Board Class 10 Date Sheet 2024: The HBSE Class 10 exam timetable 2024 will be released on bseh.org.in. Check here the expected HBSE 2024 exam schedule for Classes 10.